StonvexLoading…
StonvexStonvexStonvexCore line items from SJM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $6.78B | $4.44B | $2.11B | $8.73B |
Operating Income | $-84.30M | $464.10M | $45.60M | $-673.90M |
Net Income | $-526.80M | $241.30M | $-43.90M | $-1.23B |
EPS (Diluted) | $-4.94 | $1.85 | $-0.41 | $-11.57 |
Total Assets | $16.27B | $17.63B | $17.74B | $17.56B |
Total Liabilities | $11.03B | $11.57B | $11.82B | $11.48B |
Cash & Equivalents | $52.80M | $62.80M | $39.30M | $69.90M |
Free Cash Flow OCF − CapEx | $672.30M | $185.30M | $-94.90M | $816.60M |
Shares Outstanding | 106.70M | 106.70M | 106.70M | 106.40M |